DocCheck AG
XETRA:AJ91
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
7.15
9.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
DocCheck AG
DocCheck AG
Cash & Cash Equivalents
DocCheck AG
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
DocCheck AG
XETRA:AJ91
|
Cash & Cash Equivalents
€14.4m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
|
CompuGroup Medical SE & Co KgaA
XETRA:COP
|
Cash & Cash Equivalents
€77.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
21%
|
|
|
Nexus AG
XETRA:NXU
|
Cash & Cash Equivalents
€17.5m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
0%
|
|
|
CHAPTERS Group AG
XETRA:CHG
|
Cash & Cash Equivalents
€50.8m
|
CAGR 3-Years
336%
|
CAGR 5-Years
113%
|
CAGR 10-Years
N/A
|
|
DocCheck AG
Glance View
DocCheck AG operates as a holding company, which specializes in healthcare growth market. The company is headquartered in Cologne, Nordrhein-Westfalen and currently employs 372 full-time employees. The company went IPO on 2011-11-04. The company operates through subsidiaries: antwerpes AG develops integrated communication concepts for the healthcare sector, including social media and digital communication with focus on e-marketing concepts, search engine optimization (SEO), search engine advertising (SEA) and search engine marketing (SEM); DocCheck Medical Services GmbH operates an online platform for healthcare professionals, such as physicians and pharmacists; DocCheck Medizinbedarf und Logistik GmbH wholesales medical products from third parties and also produces own medical products, and DocCheck Guano AG is a venture capital company with focus on e-health companies.
See Also
What is DocCheck AG's Cash & Cash Equivalents?
Cash & Cash Equivalents
14.4m
EUR
Based on the financial report for Dec 31, 2023, DocCheck AG's Cash & Cash Equivalents amounts to 14.4m EUR.
What is DocCheck AG's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
9%
Over the last year, the Cash & Cash Equivalents growth was 7%. The average annual Cash & Cash Equivalents growth rates for DocCheck AG have been -6% over the past three years , 9% over the past five years .
You don't have any saved screeners yet
